Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc.verified




Market Cap:


Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blo...[Read more]


Drug Manufacturers - Specialty & Generic

IPO Date


Stock Exchange




The PE Ratio as of May 2024 (TTM) for Eagle Pharmaceuticals, Inc. (EGRX) is 4.40

According to Eagle Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 4.40. This represents a change of 14.87% compared to the average of 3.83 of the last 4 quarters.

Eagle Pharmaceuticals, Inc. (EGRX) Historical PE Ratio (quarterly & annually)

How has EGRX PE Ratio performed in the past?

The mean historical PE Ratio of Eagle Pharmaceuticals, Inc. over the last ten years is 61.19. The current 4.40 PE Ratio has changed 619.02% with respect to the historical average. Over the past ten years (40 quarters), EGRX's PE Ratio was at its highest in in the December 2015 quarter at 283.66. The PE Ratio was at its lowest in in the June 2020 quarter at -640.28.

Quarterly (TTM)









Eagle Pharmaceuticals, Inc. (EGRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Eagle Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 209.56%

Maximum Annual PE Ratio = 525.96

Minimum Annual Increase = -7607.47%

Minimum Annual PE Ratio = -77.03

Quarterly (TTM)
YearPE RatioChange

Eagle Pharmaceuticals, Inc. (EGRX) Average PE Ratio

How has EGRX PE Ratio performed in the past?

The current PE Ratio of Eagle Pharmaceuticals, Inc. (EGRX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg


5-year avg


10-year avg


Eagle Pharmaceuticals, Inc. (EGRX) PE Ratio vs. Peers

How is EGRX’s PE Ratio compared to its peers?

Eagle Pharmaceuticals, Inc.’s PE Ratio is less than ANI Pharmaceuticals, Inc. (32.95), less than Phibro Animal Health Corporation (57.02), greater than Deciphera Pharmaceuticals, Inc. (-11.71), less than Prestige Consumer Healthcare Inc. (15.23), less than Collegium Pharmaceutical, Inc. (11.87), less than Silver Spike Investment Corp. (14.18), greater than Regencell Bioscience Holdings Limited (-11.10), less than Amphastar Pharmaceuticals, Inc. (13.48), less than Alkermes plc (9.29), greater than Evolus, Inc. (-12.26), greater than Procaps Group, S.A. (0.05), greater than Delta 9 Cannabis Inc. (-0.25), less than RAMM Pharma Corp. (0), greater than City View Green Holdings Inc. (-0.25), greater than Craftport Cannabis Corp. (-0.00), greater than Speakeasy Cannabis Club Ltd. (-0.00),

Build a custom stock screener for Eagle Pharmaceuticals, Inc. (EGRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eagle Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eagle Pharmaceuticals, Inc. (EGRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eagle Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Eagle Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Eagle Pharmaceuticals, Inc. (EGRX)?

What is the highest PE Ratio for Eagle Pharmaceuticals, Inc. (EGRX)?

What is the 3-year average PE Ratio for Eagle Pharmaceuticals, Inc. (EGRX)?

What is the 5-year average PE Ratio for Eagle Pharmaceuticals, Inc. (EGRX)?

How does the current PE Ratio for Eagle Pharmaceuticals, Inc. (EGRX) compare to its historical average?